Skip to main content

Table 5 Cumulative Baseline characteristics of women included in the study

From: Baseline characteristics of study sites and women enrolled in a three-arm cluster randomized controlled trial: PMTCT uptake and retention (pure) Malawi

 

Total

Percent

Pregnant

Percent

Lactating

Percent

P- value (Chi-square)

N

1269

 

1094

86%

175

14%

 

Health Zone

 Central West

272

21%

223

20%

49

28%

0.07

 South East

585

46%

512

47%

73

42%

 

 South West

412

32%

359

33%

53

30%

 

Age

 15–21

266

21%

224

20%

42

24%

0.30

 22–28

488

38%

419

38%

69

39%

 

 29–35

406

32%

355

32%

51

29%

 

  > 36

103

8%

94

9%

9

5%

 

 Missing

6

0.5%

2

0.2%

4

2%

 

Months pre- or postnatal at enrolment

  < 3 months

  

370

34%

42

24%

 

 3–6 months

  

582

53%

22

13%

 

  > 6 months

  

47

4%

51

29%

 

 Missing

  

97

9%

61

35%

 

WHO Stage at ART initiation

 Stage 1 (asymptomatic)

1211

95%

1044

95%

167

95%

0.12

 Stage 2

13

1%

13

1%

   

 Stage 3

10

1%

7

1%

3

2%

 

 Stage 4

-

 

-

 

-

  

 Missing

35

3%

30

3%

5

3%

 

Marital Status

 Never married

21

2%

16

1%

5

3%

0.001

 Maried Monogamous

1068

84%

942

86%

124

71%

 

 Maried Polygamous

110

9%

96

9%

13

7%

 

 Divorced

49

4%

27

2%

22

13%

 

 Widowed

17

1%

7

1%

10

6%

 

 Missing

7

1%

6

1%

1

1%

 

Currently having a sexual partner

 Yes

1193

94%

1053

96%

140

80%

0.001

 No

60

5%

29

3%

31

18%

 

 Missing

16

r

1%

12

r

1%

4

2%

 

Current sexual partner living in catchment area

 Yes

994

83%

878

83%

116

83%

0.43

 No

133

11%

118

11%

14

10%

 

 Missing

66

6%

57

5%

10

7%

 

Enrollment period

 01Oct-31Dec’13

108

9%

94

9%

14

8%

0.67

 01lan-31Mar’14

551

43%

468

43%

83

47%

 

 01Apr-30Jun’14

417

33%

362

33%

55

31%

 

 01lul -30Sep’14

186

15%

163

15%

23

13%

 

 01Oct-31Dec’14

7

1%

7

1%

   

Follow up time from Enrolment to Study End

 20–23 months

47

4%

40

4%

7

4%

0.37

 24–27 months

467

37%

411

38%

56

32%

 

 28–32 months

755

59%

643

59%

112

64%